Biocon Biologics Limited – FDA Inspection, Sep 3, 2025

Record Details

This FDA Inspection record concerns Biocon Biologics Limited, with an inspection on September 3, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Biocon Biologics Limited
Inspection Date: September 3, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Guerlain Ulysse (FDA Associated Person)

View Company Profile

ID · eafc2952-08ee-4703-9bf8-fd52a8cefc17

Inspection Facts

Inspection number: 1286258
FDA center: Human Drugs
Outcome: Form 483 issued

Other FDA inspections of Biocon Biologics Limited

Date	Classification	Office	Project area
February 28, 2024	VAI	Center for Veterinary Medicine	Pre-Approval Eval. of Animal Drugs and Food Additives

Other documents for Biocon Biologics Limited

FDA Inspection 1232776 - 2024-02-28

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Biocon Biologics Limited

Date

Classification

Office

Project area

February 28, 2024

VAI

Center for Veterinary Medicine

Pre-Approval Eval. of Animal Drugs and Food Additives